top of page

News

The United States Patent and Trademark Office has notified CNS that they will be issued a patent on December 27th, 2022, for several unique pharmaceuticals which we believe will be useful for treating neurodegenerative diseases.

On Wednesday, November 2nd, Dr. Smith's abstract regarding alpha-synuclein seed-amplification was presented at the NEALS convention in Clearwater, Florida.


The presentation was given by one of the authors, Dr. Robert Bowser and the poster that was presented is below.



ree



© 2021 by Center for Neurologic Study.

bottom of page